Drug-Induced Sclerosing Cholangitis Leading to Discontinuation of Treatment in a Patient with Metastatic Breast Cancer: A Case Report
This case highlights the possibility of SC as a delayed adverse event of anticancer chemotherapy. Clinicians should consider drug-induced SC when unexplained biliary strictures arise during or after chemotherapy, as early recognition may impact prognosis and treatment planning.
Authors
- Chikako Shimizu (ORCID: https://orcid.org/0000-0003-1448-5865)
- Yayoi Honda
- Akihiko Shimomura (ORCID: https://orcid.org/0000-0002-2557-8170)
- Hoshie Hirai
- Kenta Aso
- Kento Misumi
- Shotaro Aso (ORCID: https://orcid.org/0000-0002-7804-2433)
- Dai Kitagawa (ORCID: https://orcid.org/0000-0002-9636-8488)
- Takeyuki Watadani (ORCID: https://orcid.org/0000-0002-3587-9356)
Institutions
- Juntendo University (JP)
- National Center for Global Health and Medicine (JP)
Publication Details
- Journal
- Case Reports in Oncology
- Published
- 2025-12-06
- DOI
- https://doi.org/10.1159/000549968
- Primary Topic
- Liver Diseases and Immunity
- Type
- article
- Field-Weighted Citation Impact
- 0.00